Showing results (1041-1050 of 1,205) with videos related to

Sort By:
Pageof 121
Breast Cancer Research and Treatment|August 2, 2019
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancerVandana G Abramson, Mafalda Oliveira, Andrés Cervantes, et al.
The American Surgeon|February 1, 2021
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal AdenocarcinomaJames S Strong, Elvira L Vos, Caitlin A Mcintyre, et al.
Annals of Surgical Oncology|March 24, 2026
Hepatic Artery Infusion Pump Chemotherapy Associated Biliary Sclerosis After Treatment for Colorectal Cancer Liver MetastasisAnkur P Choubey, Kenneth Seier, Lauren Schleimer, et al.
Annals of Surgical Oncology|July 11, 2020
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump ChemotherapyFlorian E Buisman, Wills F Filipe, Nancy E Kemeny, et al.
Annals of Surgical Oncology|October 30, 2025
Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver MetastasesOmar A Zaki, Raja R Narayan, Rami Srouji, et al.
Cancer|September 10, 2025
Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinomaSean J Judge, Emily Manin, Joanne Chou, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 14, 2022
Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinomaJoshua S Jolissaint, Tiegong Wang, Kevin C Soares, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|July 27, 2022
[Study on mechanisms of Th17/Treg imbalance in patients with cystic echinococcosis based on miRNA expression profiles]D Lu, J H Song, Z J Ma, et al.
Journal of the National Cancer Institute|May 11, 2026
Prediction of resection after preoperative FOLFIRINOX in patients with localized pancreatic adenocarcinoma: a Trans-Atlantic Pancreatic Surgery (TAPS) Consortium studyE M M Verkolf, J L van Dam, E N Dekker, et al.
American Journal of Hematology|June 12, 2026
A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell LymphomaJulio C Chavez, Mariana Bastos-Oreiro, Catherine Diefenbach, et al.
Pageof 121